Pharmaceutical composition for preventing or treating diabetic complications
US11607445B2 · kind B2 · utility
0Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 19, 2020 |
| Grant date | Mar 21, 2023 |
| Priority date | — |
| Expiry date | Mar 19, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a composition and a method for the prevention or treatment of diabetic complications, which includes C-peptide bound to elastin-like polypeptide (ELP) and is thus capable of effectively preventing or treating diseases resulting from hyperglycemia, which is a major cause of diabetes, for example, diabetic retinopathy, and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.